Debunked Episode 19: Turmoil at the CDC, Epic’s AI Strategy
The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC.
The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC.
Susan Monarez has been fired from her role as CDC director less than a month after her confirmation, following reported clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine policy. This news comes amid a period of turmoil at the CDC, including a recent deadly shooting at its headquarters.
His longstanding anti-vaccine rhetoric and vocal opposition to science-backed expert consensus has caused widespread concern among public health and medical professionals about the appropriateness of his leadership.
The Trump administration's healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch.
FDA approval of Merck’s RSV antibody drug, Enflonsia, makes it a direct competitor to Sanofi’s Beyfortus. The new Merck product is expected to be discussed by the CDC’s Advisory Committee on Immunization Practices; ACIP will have an entirely new roster at its next meeting after all 17 sitting members were dismissed by Health and Human Services Secretary Robert F. Kennedy Jr.
President Donald Trump selected Susan Monarez — the current acting director of the Centers for Disease Control and Prevention — to lead the agency going forward. This nomination replaces one that the White House withdrew on March 13, after it became clear that physician and former Republican congressman Dave Weldon would not receive enough Senate votes to be confirmed.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) is considering certain changes to the current meningococcal vaccination schedule. Here's why the ACIP should scrap that proposal.
In the face of new variants and lower public acceptance of vaccination, it’s imperative that we take stock of lessons learned from previous seasons and examine key barriers to uptake as we prepare for this fall and winter – from adjusting approval timelines at the federal level, to implementing programs to address vaccine complacency, convenience and confidence.
The CDC recently issued an advisory about a bacteria called shigella due to a nationwide increase in infections resulting from drug-resistant strains. The easily transmissible bacteria causes an infection called shigellosis that is uncomfortable and unpleasant but rarely life-threatening — the main symptom is inflammatory diarrhea.
In 2021, 69% of LGBQ+ teens reported experiencing persistent feelings of sadness or hopelessness in the past year, compared to 35% of heterosexual teens, according to a recent CDC report. This stat is likely understated because the report did not include information about those who identify as transgender, experts said.
Gun violence is a public health crisis, and lawmakers are taking small steps toward treating it that way, said Kris Brown, president of gun violence prevention nonprofit Brady United. But there is still a long road ahead in the fight to protect American communities against gun-related injuries and fatalities, she said.
The report, released by Kaiser Family Foundation and the Peterson Center on Healthcare, details the high cost of Covid care for the unvaccinated. In fact, the analysis indicates the figure could be even higher than $2.3 billion, as the authors did not take into account the cost of outpatient treatment for Covid-19.
President Joe Biden has submitted his discretionary budget for 2022 to Congress. Among its healthcare provisions are funding requests for the CDC, mental health and social determinants of health programs. But there are some unusual requests as well, such as funding for an Office of Climate Change and Health Equity.
In an address on Thursday, President Joe Biden directed states to make all adults eligible for the Covid-19 vaccine no later than May 1. To get there, the Administration is buying more doses, and ramping up more vaccination sites in partnership with local clinics and pharmacies.
The CDC has engaged the California-based health system's Vaccine Study Center to conduct an analysis of its Covid-19 vaccine data with the aim of pinpointing adverse events and reactions. The collaboration will continue for the next three years.